Direct measurement of free estradiol in human serum by equilibrium dialysis-liquid chromatography-tandem mass spectrometry and reference intervals of free estradiol in women

Clinica Chimica Acta

Volumn 413, Issue 11-12, 2012, Pages 1008-1014

  Ray, Julie A ^a   Kushnir, Mark M ^a   Bunker, Ashley ^a   Rockwood, Alan L ^a   Meikle, A Wayne ^a,b  

^a ARUP INSTITUTE FOR CLINICAL AND EXPERIMENTAL PATHOLOGY   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Equilibrium dialysis; Free estradiol; LC MS MS; MRM; Reference intervals; SHBG

Indexed keywords

ESTRADIOL;

ADULT; ARTICLE; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DERIVATIZATION; EQUILIBRIUM DIALYSIS; FEMALE; FOLLICULAR PHASE; HUMAN; HUMAN EXPERIMENT; LIMIT OF DETECTION; LIQUID CHROMATOGRAPHY; LIQUID LIQUID EXTRACTION; LUTEAL PHASE; MULTIPLE REACTION MONITORING; NORMAL HUMAN; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; REFERENCE VALUE; TANDEM MASS SPECTROMETRY;

ADULT; CHROMATOGRAPHY, LIQUID; DIALYSIS; ESTRADIOL; FEMALE; HUMANS; MENSTRUAL CYCLE; POSTMENOPAUSE; PREMENOPAUSE; REFERENCE VALUES; SEX HORMONE-BINDING GLOBULIN; TANDEM MASS SPECTROMETRY;

EID: 84859425453     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2012.02.028     Document Type: Article

References (37)

1. Nikolov I.T., Dimitrov O.A. Estradiol binding by serum proteins in the postmenopause of women with breast cancer. Probl Endokrinol (Mosk) 1990, 36:40-43.
2. Levin E., Tomchinsky S., Lopez S. Displacement by tamoxifen of the estradiol-estrogen receptor binding: a functional assay for breast cancer studies. J Steroid Biochem Mol Biol 1990, 37:681-686.
3. Maynadier M., Nirde P., Ramirez J.M., et al. Role of estrogens and their receptors in adhesion and invasiveness of breast cancer cells. Adv Exp Med Biol 2008, 617:485-491.
4. Seeger H., Wallwiener D., Kraemer E., Mueck A.O. Estradiol metabolites are potent mitogenic substances for human ovarian cancer cells. Eur J Gynaecol Oncol 2005, 26:383-385.
5. Song J., Fadiel A., Edusa V., et al. Estradiol-induced ezrin overexpression in ovarian cancer: a new signaling domain for estrogen. Cancer Lett 2005, 220:57-65.
6. Kang S.K., Choi K.C., Tai C.J., Auersperg N., Leung P.C. Estradiol regulates gonadotropin-releasing hormone (GnRH) and its receptor gene expression and antagonizes the growth inhibitory effects of GnRH in human ovarian surface epithelial and ovarian cancer cells. Endocrinology 2001, 142:580-588.
7. Lee S.H., Kim K.M., Jung B.H., Chung W.Y., Park C.S., Chung B.C. Estrogens in female thyroid cancer: alteration of urinary profiles in pre- and post-operative cases. Cancer Lett 2003, 189:27-32.
8. Kumar A., Klinge C.M., Goldstein R.E. Estradiol-induced proliferation of papillary and follicular thyroid cancer cells is mediated by estrogen receptors alpha and beta. Int J Oncol 2010, 36:1067-1080.
9. Banu K.S., Govindarajulu P., Aruldhas M.M. Testosterone and estradiol have specific differential modulatory effect on the proliferation of human thyroid papillary and follicular carcinoma cell lines independent of TSH action. Endocr Pathol 2001, 12:315-327.
10. Fontan Balestra E. Pre-menstrual diseases; hepato-adreno-psychiatric syndrome due to estrogen deficiency. Dia Med 1951, 23:1870-1875.
11. Seippel L., Backstrom T. Luteal-phase estradiol relates to symptom severity in patients with premenstrual syndrome. J Clin Endocrinol Metab 1998, 83:1988-1992.
12. Bulun S.E., Gurates B., Fang Z., et al. Mechanisms of excessive estrogen formation in endometriosis. J Reprod Immunol 2002, 55:21-33.
13. Delvoux B., Groothuis P., D'Hooghe T., Kyama C., Dunselman G., Romano A. Increased production of 17beta-estradiol in endometriosis lesions is the result of impaired metabolism. J Clin Endocrinol Metab 2009, 94:876-883.
14. Akoum A., Jolicoeur C., Boucher A. Estradiol amplifies interleukin-1-induced monocyte chemotactic protein-1 expression by ectopic endometrial cells of women with endometriosis. J Clin Endocrinol Metab 2000, 85:896-904.
15. Pastides H., Najjar M.A., Kelsey J.L. Estrogen replacement therapy and fibrocystic breast disease. Am J Prev Med 1987, 3:282-286.
16. Fowler P.A., Sorsa-Leslie T., Harris W., Mason H.D. Ovarian gonadotrophin surge-attenuating factor (GnSAF): where are we after 20years of research?. Reproduction 2003, 126:689-699.
17. Kreiner D., Droesch K., Itskovitz J., Liu H.C., Navot D., Rosenwaks Z. Spontaneous luteinizing hormone (LH) surges are associated with more rapidly increasing estradiol (E2) and follicle stimulating hormone (FSH) in in vitro fertilization and embryo transfer. J In Vitro Fert Embryo Transf 1988, 5:265-267.
18. Fortunati N., Catalano M.G., Boccuzzi G., Frairia R. Sex hormone-binding globulin (SHBG), estradiol and breast cancer. Mol Cell Endocrinol 2010, 316:86-92.
19. Hammond G.L. Potential functions of plasma steroid-binding proteins. Trends Endocrinol Metab 1995, 6:298-304.
20. Hammond G.L. Access of reproductive steroids to target tissues. Obstet Gynecol Clin North Am 2002, 29:411-423.
21. Mendel C.M. The free hormone hypothesis. Distinction from the free hormone transport hypothesis. J Androl 1992, 13:107-116.
22. Sodergard R., Backstrom T., Shanbhag V., Carstensen H. Calculation of free and bound fractions of testosterone and estradiol-17 beta to human plasma proteins at body temperature. J Steroid Biochem 1982, 16:801-810.
23. Mazer N.A. A novel spreadsheet method for calculating the free serum concentrations of testosterone, dihydrotestosterone, estradiol, estrone and cortisol: with illustrative examples from male and female populations. Steroids 2009, 74:512-519.
24. Rinaldi S., Geay A., Dechaud H., et al. Validity of free testosterone and free estradiol determinations in serum samples from postmenopausal women by theoretical calculations. Cancer Epidemiol Biomarkers Prev 2002, 11:1065-1071.
25. MacMahon W., Stallings J., Sgoutas D. A simple ultrafiltration method for determining unbound estradiol in serum. Clin Biochem 1983, 16:240-243.
26. Wheeler M.J. The determination of bio-available testosterone. Ann Clin Biochem 1995, 32(Pt 4):345-357.
27. Khosla S., Melton L.J., Atkinson E.J., O'Fallon W.M., Klee G.G., Riggs B.L. Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen. J Clin Endocrinol Metab 1998, 83:2266-2274.
28. Yue B., Rockwood A.L., Sandrock T., La'ulu S.L., Kushnir M.M., Meikle A.W. Free thyroid hormones in serum by direct equilibrium dialysis and online solid-phase extraction-liquid chromatography/tandem mass spectrometry. Clin Chem 2008, 54:642-651.
29. Kushnir M.M., Rockwood A.L., Yue B., Meikle A.W. High sensitivity measurement of estrone and estradiol in serum and plasma using LC-MS/MS. Methods Mol Biol 2010, 603:219-228.
30. Annesley T.M. Ion suppression in mass spectrometry. Clin Chem 2003, 49:1041-1044.
31. Kushnir M.M., Rockwood A.L., Bergquist J., et al. High-sensitivity tandem mass spectrometry assay for serum estrone and estradiol. Am J Clin Pathol 2008, 129:530-539.
32. Holm S.S., Andreasen L., Hansen S.H., Faber J., Staun-Olsen P. Influence of adsorption and deproteination on potential free thyroxine reference methods. Clin Chem 2002, 48:108-114.
33. Van Uytfanghe K., Stockl D., Kaufman J.M., et al. Evaluation of a candidate reference measurement procedure for serum free testosterone based on ultrafiltration and isotope dilution-gas chromatography-mass spectrometry. Clin Chem 2004, 50:2101-2110.
34. Jung D., Mayersohn M., Perrier D. The "ultra-free" ultrafiltration technique compared with equilibrium dialysis for determination of unbound thiopental concentrations in serum. Clin Chem 1981, 27:166-168.
35. Nelson J.C., Wilcox R.B., Pandian M.R. Dependence of free thyroxine estimates obtained with equilibrium tracer dialysis on the concentration of thyroxine-binding globulin. Clin Chem 1992, 38:1294-1300.
36. Boudinot F.D., Jusko W.J. Fluid shifts and other factors affecting plasma protein binding of prednisolone by equilibrium dialysis. J Pharm Sci 1984, 73:774-780.
37. Obminski Z. Changes in the free (unbound) fraction of testosterone in serum in vitro as affected by pH and temperature. Exp Clin Endocrinol Diabetes 1998, 106:85-88.